Molecular mechanisms of increased cerebral vulnerability after repeated mild blast-induced traumatic brain injury

Translational Proteomics

Volumn 3, Issue , 2014, Pages 22-37

  Kamnaksh, Alaa ^a   Ahmed, Farid ^a   Kovesdi, Erzsebet ^c   Barry, Erin S ^a,b   Grunberg, Neil E ^b   Long, Joseph B ^d   Agoston, Denes V ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Blast; Cerebral vulnerability; Neurobehavior; Protein biomarkers; Traumatic brain injury

Indexed keywords

ALPHA6 INTEGRIN; AQUAPORIN 1; AQUAPORIN 4; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD53 ANTIGEN; CERULOPLASMIN; CHEMOKINE RECEPTOR CCR5; CLAUDIN 5; CREATINE KINASE BB; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1 ALPHA; FETAL LIVER KINASE 1; FIBRINOGEN; FORMYLPEPTIDE RECEPTOR; GALECTIN; HYDROXY 2 NONEAL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC ENOLASE; PROTEIN S100B; TAU PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD ANALYSIS; BRAIN REGION; CELL ADHESION; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; DEPRESSION; FUNCTIONAL ASSESSMENT; GLIA CELL; HEART RATE; INCREASED CEREBRAL VULNERABILITY; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM PARAMETERS; NONHUMAN; OXIDATIVE STRESS; OXYGEN SATURATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEOMICS; RAT; TRAUMATIC BRAIN INJURY;

RATTUS;

EID: 84994410145     PISSN: 22129626     EISSN: 22129634     Source Type: Journal    
DOI: 10.1016/j.trprot.2013.11.001     Document Type: Article

References (85)

1. Laker S.R. Epidemiology of concussion and mild traumatic brain injury. PM R 2011, 3:S354-S358.
2. Khurana V.G., Kaye A.H. An overview of concussion in sport. J Clin Neurosci 2012, 19:1-11.
3. Stern R.A., Riley D.O., Daneshvar D.H., Nowinski C.J., Cantu R.C., McKee A.C. Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PM R 2011, 3:S460-S467.
4. Povlishock J.T. The window of risk in repeated head injury. J Neurotrauma 2013, 30:1.
5. Signoretti S., Lazzarino G., Tavazzi B., Vagnozzi R. The pathophysiology of concussion. PM R 2011, 3:S359-S368.
6. Fujita M., Wei E.P., Povlishock J.T. Intensity- and interval-specific repetitive traumatic brain injury can evoke both axonal and microvascular damage. J Neurotrauma 2012, 29:2172-2180.
7. Prins M.L., Hales A., Reger M., Giza C.C., Hovda D.A. Repeat traumatic brain injury in the juvenile rat is associated with increased axonal injury and cognitive impairments. Dev Neurosci 2010, 32:510-518.
8. Prins M.P.D., Alexander D., Giza C.C., Hovda D. Repeat mild traumatic brain injury: mechanisms of cerebral vulnerability. J Neurotrauma 2013, 30(1):30-38. 10.1089/neu.2012.2399.
9. Signoretti S., Vagnozzi R., Tavazzi B., Lazzarino G. Biochemical and neurochemical sequelae following mild traumatic brain injury: summary of experimental data and clinical implications. Neurosurg Focus 2010, 29:E1.
10. Ahmed F.A., Kamnaksh A., Kovesdi E., Long J.B., Agoston D.V. Long-term consequences of single and multiple mild blast exposure on select physiological parameters and blood-based biomarkers. Electrophoresis 2013, 34:2229-2233. 10.1002/elps.201300077.
11. Kamnaksh A., Kwon S.K., Kovesdi E., Ahmed F., Barry E.S., Grunberg N.E., et al. Neurobehavioral, cellular, and molecular consequences of single and multiple mild blast exposure. Electrophoresis 2012, 33:3680-3692.
12. Kovesdi E., Kamnaksh A., Wingo D., Ahmed F., Grunberg N.E., Long J.B., et al. Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. Front Neurol 2012, 3:111.
13. Ahmed F., Gyorgy A., Kamnaksh A., Ling G., Tong L., Parks S., et al. Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis 2012, 33:3705-3711.
14. Kwon S.K., Kovesdi E., Gyorgy A.B., Wingo D., Kamnaksh A., Walker J., et al. Stress and traumatic brain injury: a behavioral, proteomics, and histological study. Front Neurol 2011, 2:12.
15. Gyorgy A., Ling G., Wingo D., Walker J., Tong L., Parks S., et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma 2011, 28:1121-1126.
16. Gyorgy A.B., Walker J., Wingo D., Eidelman O., Pollard H.B., Molnar A., et al. Reverse phase protein microarray technology in traumatic brain injury. J Neurosci Methods 2010, 192:96-101.
17. Kamnaksh A., Kovesdi E., Kwon S.K., Wingo D., Ahmed F., Grunberg N.E., et al. Factors affecting blast traumatic brain injury. J Neurotrauma 2011, 28:2145-2153.
18. Elliott B.M., Grunberg N.E. Effects of social and physical enrichment on open field activity differ in male and female Sprague-Dawley rats. Behav Brain Res 2005, 165:187-196.
19. Agoston D.V., Gyorgy A., Eidelman O., Pollard H.B. Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades. J Neurotrauma 2009, 26:901-911.
20. Jakab G., Szallasi A., Agoston D. The calcitonin gene-related peptide (CGRP) phenotype is expressed early and up-regulated by resiniferatoxin (RTX) in mouse sensory neurons. Brain Res Dev Brain Res 1994, 80:290-294.
21. Jaffee M.S., Meyer K.S. A brief overview of traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) within the Department of Defense. Clin Neuropsychol 2009, 23:1291-1298.
22. Morey R.A., Haswell C.C., Selgrade E.S., Massoglia D., Liu C., Weiner J., et al. Effects of chronic mild traumatic brain injury on white matter integrity in Iraq and Afghanistan war veterans. Hum Brain Mapp 2013, 34(11):2986-2999. 10.1002/hbm.22117.
23. Wang Y., Wei Y., Oguntayo S., Wilkins W., Arun P., Valiyaveettil M., et al. Tightly coupled repetitive blast-induced traumatic brain injury: development and characterization in mice. J Neurotrauma 2011, 28:2171-2183.
24. Shin L.M., Rauch S.L., Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 2006, 1071:67-79.
25. Sripada R.K., Rauch S.A., Tuerk P.W., Smith E., Defever A.M., Mayer R.A., et al. Mild traumatic brain injury and treatment response in prolonged exposure for PTSD. J Trauma Stress 2013, 26:369-375.
26. de Pablos R.M., Villaran R.F., Arguelles S., Herrera A.J., Venero J.L., Ayala A., et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 2006, 26:5709-5719.
27. Fuster J.M. The prefrontal cortex - an update: time is of the essence. Neuron 2001, 30:319-333.
28. Hinwood M., Tynan R.J., Charnley J.L., Beynon S.B., Day T.A., Walker F.R. Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb Cortex 2013, 23(8):1784-1797. 10.1093/cercor/bhs151.
29. Teffer K., Semendeferi K. Human prefrontal cortex: evolution, development, and pathology. Prog Brain Res 2012, 195:191-218.
30. Abdul-Muneer P.M., Schuetz H., Wang F., Skotak M., Jones J., Gorantla S., et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med 2013, 60:282-291.
31. Kochanek P.M., Dixon C.E., Shellington D.K., Shin S.S., Bayir H., Jackson E.K., et al. Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats. J Neurotrauma 2013, 30:920-937.
32. Yeh S.H., Ou L.C., Gean P.W., Hung J.J., Chang W.C. Selective inhibition of early-but not late-expressed HIF-1alpha is neuroprotective in rats after focal ischemic brain damage. Brain Pathol 2011, 21(3):249-262. 10.1111/j.1750-3639.2010.00443.x.
33. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9-22.
34. Rosenstein J.M., Krum J.M. New roles for VEGF in nervous tissue - beyond blood vessels. Exp Neurol 2004, 187:246-253.
35. Venero J.L., Vizuete M.L., Machado A., Cano J. Aquaporins in the central nervous system. Prog Neurobiol 2001, 63:321-336.
36. Zador Z., Stiver S., Wang V., Manley G.T. Role of aquaporin-4 in cerebral edema and stroke. Handb Exp Pharmacol 2009, 15:9-70.
37. Paulinska P., Spiel A., Jilma B. Role of von Willebrand factor in vascular disease. Hamostaseologie 2009, 29:32-38.
38. Cederberg D., Siesjo P. What has inflammation to do with traumatic brain injury. Childs Nerv Syst 2010, 26:221-226.
39. Helmy A., De Simoni M.G., Guilfoyle M.R., Carpenter K.L., Hutchinson P.J. Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol 2011, 95:352-372.
40. Tsai Y.D., Liliang P.C., Cho C.L., Chen J.S., Lu K., Liang C.L., et al. Delayed neurovascular inflammation after mild traumatic brain injury in rats. Brain Injury 2013, 27:361-365.
41. Israelsson C., Bengtsson H., Kylberg A., Kullander K., Lewen A., Hillered L., et al. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma 2008, 25:959-974.
42. Dejonckheere E., Vandenbroucke R.E., Libert C. Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression. Cytokine Growth Factor Rev 2011, 22:73-81.
43. Gardner J., Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 2003, 74:801-806.
44. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukocyte Biol 2007, 82:1375-1381.
45. Almkvist J., Karlsson A. Galectins as inflammatory mediators. Glycoconj J 2004, 19:575-581.
46. Hua F., Wang J., Ishrat T., Wei W., Atif F., Sayeed I., et al. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflamm 2011, 8:42.
47. Yao L., Kan E.M., Lu J., Hao A., Dheen S.T., Kaur C., et al. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflamm 2013, 10:23.
48. Shin T. Osteopontin as a two-sided mediator in acute neuroinflammation in rat models. Acta Histochem 2012, 114:749-754.
49. Minami M., Satoh M. Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sci 2003, 74:321-327.
50. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 2005, 48:16-42.
51. Kumar A., Loane D.J. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 2012, 26:1191-1201.
52. Woodcock T., Morganti-Kossmann M.C. The role of markers of inflammation in traumatic brain injury. Front Neurol 2013, 4:18.
53. Franzen R., Bouhy D., Schoenen J. Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor'. Neurosci Lett 2004, 361:76-78.
54. Thomas W.E. Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 1992, 17:61-74.
55. Barron K.D. The microglial cell. A historical review. J Neurol Sci 1995, 134(Suppl.):57-68.
56. Hailer N.P. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 2008, 84:211-233.
57. Sorce S., Myburgh R., Krause K.H. The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol 2011, 93:297-311.
58. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002, 202:13-23.
59. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008, 212:108-117.
60. Belanger M., Magistretti P.J. The role of astroglia in neuroprotection. Dialogues Clin Neurosci 2009, 11:281-295.
61. Chvatal A., Anderova M., Neprasova H., Prajerova I., Benesova J., Butenko O., et al. Pathological potential of astroglia. Physiol Res/Acad Sci Bohemoslov 2008, 57(Suppl. 3):S101-S110.
62. Floyd C.L., Lyeth B.G. Astroglia: important mediators of traumatic brain injury. Prog Brain Res 2007, 161:61-79.
63. Taber K.H., Hurley R.A. Astroglia: not just glue. J Neuropsychiatry Clin Neurosci 2008, 20:iv-129.
64. Verkhratsky A., Parpura V. Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin 2010, 31:1044-1054.
65. Andrews M.R., Czvitkovich S., Dassie E., Vogelaar C.F., Faissner A., Blits B., et al. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci 2009, 29:5546-5557.
66. Gardner J., Borgmann K., Deshpande M.S., Dhar A., Wu L., Persidsky R., et al. Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J Neurosci Res 2006, 83:1281-1292.
67. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A.W., Miller K., et al. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 2002, 15:19-32.
68. Bouvier D., Fournier M., Dauphin J.B., Amat F., Ughetto S., Labbe A., et al. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clin Chem 2012, 58:1116-1122.
69. Yates D. Traumatic brain injury: serum levels of GFAP and S100B predict outcomes in TBI. Nat Rev Neurol 2011, 7:63.
70. Rainey T., Lesko M., Sacho R., Lecky F., Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Resuscitation 2009, 80:341-345.
71. Morochovic R., Racz O., Kitka M., Pingorova S., Cibur P., Tomkova D., et al. Serum S100B protein in early management of patients after mild traumatic brain injury. Eur J Neurol 2009, 16:1112-1117.
72. Thelin E.P., Johannesson L.K., Nelson D.W., Bellander B.M. S100B is an important outcome predictor in traumatic brain injury. J Neurotrauma 2013, 30(7):519-528. 10.1089/neu.2012.2553.
73. Mondello S., Jeromin A., Buki A., Bullock R., Czeiter E., Kovacs N., et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma 2012, 29:1096-1104.
74. Czeiter E., Mondello S., Kovacs N., Sandor J., Gabrielli A., Schmid K., et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma 2012, 29:1770-1778.
75. Svetlov S.I., Prima V., Glushakova O., Svetlov A., Kirk D.R., Gutierrez H., et al. Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to "composite" blast. Front Neurol 2012, 3:15.
76. Berger R.P., Adelson P.D., Richichi R., Kochanek P.M. Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev Neurosci 2006, 28:327-335.
77. Karkela J., Bock E., Kaukinen S. CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 1993, 116:100-109.
78. Rosen H., Sunnerhagen K.S., Herlitz J., Blomstrand C., Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001, 49:183-191.
79. Schmitt B., Bauersfeld U., Schmid E.R., Tuchschmid P., Molinari L., Fanconi S., et al. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury?. Brain Dev 1998, 20:536-539.
80. Gabbita S.P., Scheff S.W., Menard R.M., Roberts K., Fugaccia I., Zemlan F.P. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 2005, 22:83-94.
81. Huber B.R., Meabon J.S., Martin T.J., Mourad P.D., Bennett R., Kraemer B.C., et al. Blast exposure causes early and persistent aberrant phospho- and cleaved-tau expression in a murine model of mild blast-induced traumatic brain injury. J Alzheimers Dis 2013, 37(2):309-323. 10.3233/JAD-130182.
82. Liliang P.C., Liang C.L., Lu K., Wang K.W., Weng H.C., Hsieh C.H., et al. Relationship between injury severity and serum tau protein levels in traumatic brain injured rats. Resuscitation 2010, 81:1205-1208.
83. Liliang P.C., Liang C.L., Weng H.C., Lu K., Wang K.W., Chen H.J., et al. Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 2010, 160:302-307.
84. Ojo J.O., Mouzon B., Greenberg M.B., Bachmeier C., Mullan M., Crawford F. Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice. J Neuropathol Exp Neurol 2013, 72:137-151.
85. Ost M., Nylen K., Csajbok L., Ohrfelt A.O., Tullberg M., Wikkelso C., et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006, 67:1600-1604.